InMode to Present at the 25th Annual Needham Virtual Healthcare Conference
Rhea-AI Summary
InMode (Nasdaq: INMD) announced that CEO Moshe Mizrahy and CFO Yair Malca will present at the 25th Annual Needham Virtual Healthcare Conference on Monday, April 13, 2026, at 11:00 AM Eastern Time. The session is a fireside chat moderated by Michael Matson.
A live webcast of the presentation will be available and InMode will hold virtual one-on-one investor meetings the same day; scheduling is via Needham representatives and additional event details are on the company's investor relations site.
Positive
- None.
Negative
- None.
News Market Reaction – INMD
In the Mar 24 session, INMD declined 0.22%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Mar 13 | Share repurchase plan | Positive | +6.1% | Authorized buyback up to about 10% of shares outstanding. |
| Feb 26 | Investor conferences | Positive | +0.6% | Announced March presentations at Barclays and Oppenheimer healthcare conferences. |
| Feb 23 | Transaction review outcome | Negative | -6.7% | Committee ended potential-transaction process after deeming proposals inadequate. |
| Feb 10 | Earnings release | Neutral | -3.3% | Reported Q4 and FY 2025 results with 2026 revenue and EPS guidance. |
| Feb 03 | BTIG conference | Neutral | -4.3% | Planned CFO-led investor meetings at BTIG MedTech conference. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent news with clearly positive framing (buybacks, conferences) often saw aligned positive or modest reactions, while more uncertain or mixed items (transaction review, earnings) leaned negative but still directionally aligned.
Over the last several months, InMode’s news flow has centered on capital allocation, investor outreach, and strategic review outcomes. A new share repurchase program on Mar 13, 2026 coincided with a 6.11% gain, while multiple conference appearances in February saw small or negative moves. The independent transaction committee’s decision on Feb 23, 2026 and the Q4/FY 2025 earnings release both drew negative reactions, highlighting sensitivity to strategic and financial updates. Today’s Needham conference appearance fits the ongoing investor-relations push.
AI-generated analysis. How Rhea-AI works. Not financial advice.
YOKNEAM,
The fireside chat, moderated by Michael Matson, Senior Equity Analyst, is scheduled for 11:00 am Eastern Time on Monday, April 13, and a live webcast of the presentation can be accessed here. InMode will also hold virtual one-on-one investor meetings that same day. To schedule a meeting, please contact your Needham representative.
For more information about the event, visit InMode's investor relations site here.
About InMode
InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radiofrequency ("RF") technology. InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode and its wide array of medical technologies, visit www.inmodemd.com.
Forward-Looking Statements
The information in this press release includes forward-looking statements within the meaning of the federal securities laws. These statements generally relate to future events or InMode's future financial or operating performance, including the actual amount of share repurchases made by the Company, if any. Actual outcomes and results may differ materially from what is expressed or forecast in such forward-looking statements. In some cases, you can identify these statements because they contain words such as "anticipate," "believe," "estimate," "expect," "intend," "may," "plan," "predict," "project," "will," "would" and similar expressions that concern our expectations, strategic plans or intentions. Forward-looking statements are based on management's current expectations and assumptions, and are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Consequently, actual results could differ materially from those indicated in these forward-looking statements. When considering these forward-looking statements, you should keep in mind the risk factors and other cautionary statements included in InMode's Annual Report on Form 20-F filed with the Securities and Exchange Commission on February 10, 2026, and our subsequent public filings. InMode undertakes no obligation and does not intend to update these forward-looking statements to reflect events or circumstances occurring after this press release. You are cautioned not to place undue reliance on these forward-looking statements, which pertain only as of the date of this press release.
Investor Relations Contact:
Miri Segal-Scharia
MS-IR LLC
ir@inmodemd.com
Logo - https://mma.prnewswire.com/media/1064477/5878507/InMode_Logo.jpg
View original content to download multimedia:https://www.prnewswire.com/news-releases/inmode-to-present-at-the-25th-annual-needham-virtual-healthcare-conference-302722319.html
SOURCE InMode Ltd.